Skip to main content
. 2017 Jun 15;6(3):19. doi: 10.1167/tvst.6.3.19

Figure 1.

Figure 1

Kaplan Meier Survival Analysis for patient population. The Kaplan Meier Survival Analysis showed that 23.9% of the patients develop ADDE by 6-month postcompletion of radiotherapy, 50.2% by the end of 18.8 months, and 77.2% by the end of 47.17 months. Solid line indicates the data curve; dotted lines represent the confidence intervals.